Life ScienceCompany
GlaxoSmithKline - Wellbutrin XL Ownership
Who owns GlaxoSmithKline - Wellbutrin XL?
GlaxoSmithKline - Wellbutrin XL is owned by Biovail. It was acquired on May 6, 2009.
GlaxoSmithKline - Wellbutrin XL Business Overview
Where is GlaxoSmithKline - Wellbutrin XL headquartered?
GlaxoSmithKline - Wellbutrin XL is headquartered in United States.
What sector is GlaxoSmithKline - Wellbutrin XL in?
GlaxoSmithKline - Wellbutrin XL is a life science company.
When was GlaxoSmithKline - Wellbutrin XL founded?
GlaxoSmithKline - Wellbutrin XL was founded in 2003.
Life Science M&A Summary in 2009
Out of 60 sectors in the Mergr database, life science ranked 6 in number of deals in 2009. The largest life science acquisition in 2009 was Wyeth - which was acquired by Pfizer for $68.0B.
Join Mergr to view all 111 acquisitions of life science companies in 2009, including 13 acquisitions by private equity firms, and 98 by strategics.